“ Vivian Zhang, Managing Director and General Manager of Merck China Healthcare, shares insights into the market’s strategic importance to the company and its current priorities in… ”
“ In a biotech company, it’s essential to explore different avenues initially, but once you identify what works best, focus your efforts there to create more value ”
“ To stay competitive, we are working to integrate China's regulatory requirements much earlier in the product lifecycle, even during the design and R&D phases. This allows… ”
“ Despite recent advances in cancer immunotherapy, approximately 80 percent of patients still do not respond, or become resistant, to currently available immuno-oncology treatments ”
“ In the past, companies used to conduct separate clinical trials in the US, Europe, and then in China. Now, with simultaneous approvals, Chinese patients can access… ”